Literature DB >> 23886162

Investigation of the antioxidant status in multiple myeloma patients: effects of therapy.

Wesen A Mehdi1, Jwan A Zainulabdeen, Atheer A Mehde.   

Abstract

BACKGROUND: Multiple myeloma is a malignant silent incurable plasma cell disorder. The present study aimed to assessed the activation of the oxidative stress pathway in affected patients.
MATERIALS AND METHODS: Advanced oxidation protein products (AOPPs), malondialdehyde (MDA), adenosine deaminase (ADA), total antioxidant capacity (TAC) levels, glutathione, ascorbic acid (vitamin C), α-tocopherol (vitamin E) in addition to related enzymes glutathione peroxidase (GSH-Px), glutathione reductase (GSH-R) and superoxide dismutase (SOD) were analyzed in sixty patients with multiple myeloma before and after one month treatment with induction therapy.
RESULTS: The results of the study showed a significant elevation in AOPPs, MDA, ADA levels in patients with multiple myeloma before and after treatment in comparison to healthy control samples In contrast TAC glutathione, vitamin C and E, and the antioxidant enzymes levels were decreased significantly. On comparing samples of MM patients after treatment, there was significant increase of TAC glutathione, vitamin C and E, and the antioxidant enzymes in parallel with decreasing AOPPs, MDA and ADA levels in comparison with samples of patients before treatment.
CONCLUSIONS: The results indicate oxidative stress and DNA damage activity increase in MM and are alleviated in response to therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886162     DOI: 10.7314/apjcp.2013.14.6.3663

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

Review 1.  Effect of vitamins C and E on cancer survival; a systematic review.

Authors:  Ozra Tabatabaei-Malazy; Leila Azadbakht; Shahrzad Mohseni; Hanieh-Sadat Ejtahed; Mostafa Qorbani; Patricia Khashayar; Bagher Larijani
Journal:  Daru       Date:  2022-09-22       Impact factor: 4.088

Review 2.  Oxidative stress and proteasome inhibitors in multiple myeloma.

Authors:  Brittany C Lipchick; Emily E Fink; Mikhail A Nikiforov
Journal:  Pharmacol Res       Date:  2016-01-29       Impact factor: 7.658

Review 3.  Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Authors:  E Klimant; H Wright; D Rubin; D Seely; M Markman
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

4.  Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid.

Authors:  Jiliang Xia; Hongwei Xu; Xiaoyan Zhang; Chantal Allamargot; Kristen L Coleman; Randy Nessler; Ivana Frech; Guido Tricot; Fenghuang Zhan
Journal:  EBioMedicine       Date:  2017-02-16       Impact factor: 8.143

5.  Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia.

Authors:  Anitra C Carr; Emma Spencer; Andrew Das; Natalie Meijer; Carolyn Lauren; Sean MacPherson; Stephen T Chambers
Journal:  Nutrients       Date:  2020-06-24       Impact factor: 5.717

Review 6.  Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our Knowledge.

Authors:  Anitra C Carr; John Cook
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

Review 7.  High-Dose Vitamin C in Advanced-Stage Cancer Patients.

Authors:  Anna Zasowska-Nowak; Piotr Jan Nowak; Aleksandra Ciałkowska-Rysz
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

8.  Implications of Glutathione Peroxidase 3 Expression in a Cohort of Egyptian Patients with Acute Myeloid Leukemia.

Authors:  Yasmine Shaaban; Salah Aref; Mona Taalab; Mohamed Ayed; Mohamed Mabed
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

9.  The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.

Authors:  A Tagde; H Singh; M H Kang; C P Reynolds
Journal:  Blood Cancer J       Date:  2014-07-18       Impact factor: 11.037

10.  L-Ascorbic Acid Inhibits Breast Cancer Growth by Inducing IRE/JNK/CHOP-Related Endoplasmic Reticulum Stress-Mediated p62/SQSTM1 Accumulation in the Nucleus.

Authors:  Youn Kyung Choi; Jung-Il Kang; Sanghoon Han; Young Ree Kim; Jaemin Jo; Yong Woo Kang; Do Ryeon Choo; Jin Won Hyun; Young Sang Koh; Eun-Sook Yoo; Hee-Kyoung Kang
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.